뒤로Principles of Disease, Pathogenicity, Immunity, and Immunological Applications
스터디 가이드 - 스마트 노트
자료에 맞춘 맞춤형 노트, 핵심 정의, 예시, 맥락을 확장해 제공합니다.
Principles of Disease and Epidemiology
Key Definitions in Pathology
Pathology: The scientific study of disease, including its causes, development, and effects on the body.
Etiology: The study of the cause of a disease.
Infection: The invasion and multiplication of microorganisms in body tissues, which may cause disease.
Disease: An abnormal state in which the body is not functioning normally due to infection or other causes.
Human Microbiome Acquisition
Normal Microbiota: Microorganisms that colonize the body without causing disease under normal conditions.
Transient Microbiota: Microbes present for a short period; may be removed by host defenses or competition.
Acquisition: The human microbiome is acquired during and after birth, influenced by delivery mode, environment, and diet.
Symbiotic Relationships
Commensalism: One organism benefits, the other is unaffected. Example: Staphylococcus epidermidis on skin.
Mutualism: Both organisms benefit. Example: Escherichia coli in the gut synthesizes vitamins for the host.
Parasitism: One organism benefits at the expense of the other. Example: Pathogenic bacteria causing disease.
Microbial Antagonism: Normal microbiota prevent colonization by pathogens through competition and production of inhibitory substances.
Opportunistic Microorganisms
Opportunistic Pathogens: Normally harmless but can cause disease when host defenses are compromised or in unusual locations.
Communicable Disease: Spread from one host to another (e.g., influenza).
Noncommunicable Disease: Not spread from host to host (e.g., tetanus).
Koch’s Postulates
1. The microorganism must be found in all cases of the disease.
2. It must be isolated and grown in pure culture.
3. The cultured microorganism must cause disease when introduced into a healthy host.
4. It must be reisolated from the experimentally infected host.
Exceptions: Some pathogens cannot be cultured, have multiple causes, or cause different diseases in different hosts.
Incidence vs. Prevalence
Incidence: Number of new cases in a population during a specific time period.
Prevalence: Total number of cases (new and existing) at a given time.
Categories of Disease Severity
Acute: Develops rapidly, short duration (e.g., influenza).
Chronic: Develops slowly, persists (e.g., tuberculosis).
Subacute: Intermediate between acute and chronic.
Latent: Pathogen inactive for a time, then activates (e.g., herpesvirus).
Herd Immunity
Occurs when a large portion of a population is immune, reducing disease spread.
Develops through vaccination or previous infection.
Predisposing Factors for Disease
Age, gender, genetics, climate, fatigue, lifestyle, chemotherapy, and other illnesses.
Patterns and Durations of Disease
Incubation Period: Time between infection and symptom onset.
Prodromal Period: Early, mild symptoms.
Period of Illness: Most severe symptoms.
Period of Decline: Symptoms subside.
Period of Convalescence: Recovery and return to normal.
Reservoirs and Carriers
Reservoir: Continual source of infection.
Carrier: Human reservoir who harbors pathogens without symptoms.
Types: Human (e.g., carriers of typhoid), animal (e.g., bats for rabies), nonliving (e.g., soil for tetanus).
Zoonoses: Diseases transmitted from animals to humans (e.g., Zika, rabies).
Methods of Disease Transmission
Contact Transmission: Direct (person-to-person), indirect (fomites), droplet (coughing, sneezing).
Vehicle Transmission: Via water, food, or air.
Vector Transmission: Mechanical (passive, e.g., flies), biological (active, e.g., mosquitoes).
Healthcare-Associated Infections (HAIs)
Infections acquired in healthcare settings.
Important due to increased morbidity, mortality, and costs.
Compromised Host: Individual with impaired resistance to infection.
Prevention: Hand hygiene, sterilization, isolation, and surveillance.
Emerging Infectious Diseases
New or increasing in incidence.
Reasons: Microbial evolution, antibiotic misuse, climate change, travel, and animal-human contact.
Example: Zika virus spread in Central America due to vector presence and climate; limited spread in USA due to vector control and climate differences.
Epidemiology
Study of disease occurrence, distribution, and control in populations.
Morbidity: Incidence of disease.
Mortality: Deaths from disease.
Notifiable Diseases: Diseases required by law to be reported to authorities.
Microbial Mechanisms of Pathogenicity
Portals of Entry
Microorganisms enter the host via mucous membranes (respiratory, gastrointestinal, genitourinary), skin, or parenteral route (injury).
ID50 and LD50
ID50: Infectious dose for 50% of the population.
LD50: Lethal dose for 50% of the population.
Potency Comparison: Lower LD50 indicates higher potency. For example, botulinum toxin (0.03 ng/kg) is more potent than Salmonella toxin (12 mg/kg).
Adherence to Host Cells
Microbes use adhesins (e.g., fimbriae, glycocalyx) to attach to host receptors (e.g., mannose).
Drugs targeting host receptors may block pathogen adherence.
Virulence Factors
Capsules: Prevent phagocytosis (e.g., Streptococcus pneumoniae).
M Proteins: Resist phagocytosis (e.g., Streptococcus pyogenes).
Cell Wall Components: Aid in evasion of host defenses.
Enzymes: Coagulases (clot formation), kinases (clot breakdown), hyaluronidases (tissue penetration), collagenases (collagen breakdown).
Some bacteria can produce multiple enzymes simultaneously.
Antigenic Variation
Pathogens alter surface antigens to evade immune response (e.g., influenza virus).
Annual influenza vaccination is needed due to frequent antigenic changes.
Membrane Ruffling
Bacteria induce host cell cytoskeleton changes to facilitate entry (e.g., Salmonella).
Evasion of Host Defenses
Examples: S. pneumoniae (capsule), S. aureus (protein A), L. monocytogenes (intracellular growth), M. tuberculosis (resists digestion), Rickettsia (intracellular).
Toxigenicity and Direct Damage
Toxigenicity: Ability to produce toxins.
Direct Damage: Pathogen damages host cells directly during invasion.
Endotoxins vs. Exotoxins
Property | Exotoxins | Endotoxins |
|---|---|---|
Chemical Nature | Proteins | Lipopolysaccharide (LPS) |
Source | Gram-positive & Gram-negative bacteria | Gram-negative bacteria |
Heat Stability | Unstable | Stable |
Toxicity | High | Low |
Effect | Specific | General (fever, shock) |
Immunity | Stimulates antitoxin production | Weak immune response |
Exotoxins are generally more lethal due to high potency.
Food Infection vs. Food Intoxication
Food Infection: Ingestion of pathogens that grow in the host.
Food Intoxication: Ingestion of preformed toxins.
Role of Plasmids and Lysogeny
Plasmids may carry toxin or antibiotic resistance genes.
Lysogeny can convert nonpathogenic E. coli into a pathogen by introducing toxin genes.
Cytopathic Effects
Visible effects of viral infection on host cells (e.g., cell lysis, inclusion bodies).
Portals of Exit
Pathogens exit via respiratory tract, gastrointestinal tract, genitourinary tract, skin, or blood.
Antibiotic Treatment and Endotoxins
Antibiotics may lyse Gram-negative bacteria, releasing endotoxins and causing persistent symptoms (e.g., fever, low blood pressure).
Innate Immunity: Nonspecific Defenses
Innate vs. Adaptive Immunity
Innate Immunity: Nonspecific, present at birth, rapid response.
Adaptive Immunity: Specific, develops after exposure, slower response.
Toll-like Receptors (TLRs)
Proteins on host cells that recognize pathogen-associated molecular patterns (PAMPs) and activate immune responses.
Physical and Chemical Barriers
Skin: Physical barrier, acidic pH, lysozyme in sweat.
Mucous Membranes: Trap microbes, contain antimicrobial substances.
Eyes: Tears with lysozyme.
Digestive Tract: Stomach acid, digestive enzymes.
Respiratory Tract: Mucus, cilia, coughing, sneezing.
Role of Normal Microbiota
Compete with pathogens, produce inhibitory substances (antagonism).
Commensalism: One benefits, other unaffected.
Leukocyte Classification
Granulocytes: Neutrophils, eosinophils, basophils.
Agranulocytes: Monocytes, lymphocytes (T cells, B cells, NK cells), dendritic cells.
Monocytes: Differentiate into macrophages, phagocytosis.
Neutrophils: Phagocytosis, first responders to infection.
Differential Blood Count
Measures proportions of different white blood cells (WBCs).
Eight types: Neutrophils, eosinophils, basophils, monocytes, lymphocytes (T, B, NK), dendritic cells, mast cells.
Lymphatic System
Returns interstitial fluid to blood, filters pathogens via lymph nodes.
Phagocytosis
Phagocytes ingest and destroy microbes.
Resting Macrophages: Inactive, become active upon infection.
Wandering Macrophages: Move through tissues to sites of infection.
TLRs aid in adherence and activation of phagocytes.
Inflammation
Redness, swelling, pain, heat due to vasodilation and increased permeability.
Mediators: Kinins, prostaglandins, leukotrienes.
Purpose: Contain infection, remove debris, repair tissue.
Fever
Caused by pyrogens (e.g., endotoxins).
Benefits: Inhibits microbes, increases immune activity.
Complement System
Group of proteins that enhance immune responses.
Activation cascade amplifies response.
Three pathways: Classical, alternative, lectin.
Interferons and Siderophores
Interferons: Proteins that inhibit viral replication.
Siderophores: Bacterial proteins that scavenge iron from the host.
Antimicrobial Peptides (AMPs)
Produced by many organisms (e.g., humans, plants, insects).
Tested for antimicrobial activity using in vitro assays.
Nonspecific Antimicrobial Substances
Mucus: Traps microbes (found in respiratory, digestive tracts).
Lysozyme: Breaks down bacterial cell walls (found in tears, saliva).
Acidic pH: Inhibits microbial growth (found in stomach, skin).
Adaptive Immunity: Specific Defenses
Adaptive vs. Innate Immunity
Adaptive immunity is specific and has memory; vaccination induces adaptive immunity.
Humoral vs. Cellular Immunity
Humoral Immunity: Mediated by B cells and antibodies.
Cellular Immunity: Mediated by T cells.
Cytokines and Related Molecules
Cytokines: Signaling proteins in immune responses.
Interleukins: Mediate communication between leukocytes.
Chemokines: Attract immune cells to infection sites.
Interferons: Inhibit viral replication.
TNF: Inflammation and apoptosis.
Hematopoietic Cytokines: Stimulate blood cell formation.
Antigens, Epitopes, and Haptens
Antigen: Substance that elicits an immune response.
Epitope: Specific region of antigen recognized by antibodies.
Hapten: Small molecule that becomes antigenic when attached to a carrier.
Antibody Structure and Function
Y-shaped proteins with variable regions binding epitopes.
Classes: IgG, IgM, IgA, IgD, IgE (each with distinct functions).
Variable region differs among B cells.
T-Dependent vs. T-Independent Antigens
T-Dependent: Require T cell help for B cell activation.
T-Independent: Activate B cells without T cell help.
Plasmocytes and Memory Cells
Plasmocytes (plasma cells) produce antibodies but do not generate memory cells.
Clonal Selection Theory
B cells with specific receptors proliferate upon antigen exposure, producing plasma and memory cells.
Antigen-Antibody Reactions
Neutralization, agglutination, precipitation, opsonization, complement activation.
Antigen-Presenting Cells (APCs)
Cells (e.g., dendritic cells, macrophages) that present antigens to T cells.
Apoptosis
Programmed cell death, important for removing infected or abnormal cells.
Natural Killer (NK) Cells
Destroy infected or cancerous cells without prior sensitization.
Primary vs. Secondary Immune Response
Primary: First exposure, slower, lower antibody levels.
Secondary: Subsequent exposure, faster, higher antibody levels due to memory cells.
Acquisition of Antibodies
Natural infection, passive transfer (e.g., maternal antibodies), vaccination.
Thymus and Adaptive Immunity
Absence of thymus impairs T cell development; adaptive immunity is compromised.
Practical Applications of Immunology
Vaccination and Vaccine Types
Vaccination is the most effective method for controlling viral diseases.
Types: Attenuated (live, weakened), inactivated, subunit, nucleic acid (DNA, mRNA), recombinant vector.
Attenuated Vaccines: Strong, long-lasting immunity but risk in immunocompromised individuals.
Nucleic Acid/Recombinant Vector Vaccines: Safe, rapid production, no risk of infection.
DNA/mRNA vaccines are faster to produce and do not require animal cells.
Adjuvants
Substances added to vaccines to enhance immune response.
Specificity and Sensitivity
Specificity: Ability to detect only the target antigen or antibody.
Sensitivity: Ability to detect small amounts of antigen or antibody.
Immunological Tests
Agglutination Tests: Detect antigen-antibody reactions by visible clumping.
Direct Agglutination: Detects antigens on cells.
Indirect Agglutination: Uses particles coated with antigen or antibody.
ELISA (Enzyme-Linked Immunosorbent Assay): Detects antigens or antibodies using enzyme-linked indicators.
Direct ELISA: Detects antigens in a sample.
Indirect ELISA: Detects antibodies in a sample.